Published in Medicine and Law Weekly, April 21st, 2006
Recently published research in the journal Stroke reports, "Transesophageal echocardiography (TEE) is the gold standard in detecting high-risk (i.e., aortic thrombi) and potential sources (i.e., patent foramen ovale [PFO]) of cerebral embolism. We sought to evaluate the additional information and therapeutic impact provided by TEE in stroke patients and to characterize patients in whom TEE is indispensable."
"We included 503 consecutive patients (mean age 62.2 years) with acute brain...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.